Table 5.
Predictors of GI manifestation in patients with COVID-19.
| Covariate | Univariate Regression Analyses | Multivariate Regression | ||
|---|---|---|---|---|
| Exp (B) 95%CI | Significance | Exp (B) 95%CI | Significance | |
| Age | 1.190 (0.840–1.686) | p = 0.328 | / | / |
| Sex | 1.725 (1.150–2.588) | p = 0.008 * | 3.417 (1.868–6.249) | p = 0.000 * |
| Vaccination | 0.861 (0.566–1.308) | p = 0.483 | / | / |
| SpO2 | 1.020 (0.961–1.082) | p = 0.522 | / | / |
| O2/L | 1.051 (0.621–1.779) | p = 0.335 | / | / |
| Comorbidity | 1.894 (1.050–3.419) | p = 0.034 * | 0.825 (0.301–2.260) | p = 0.708 |
| CVD | 1.895 (1.109–3.238) | p = 0.019 * | 1.716 (0.907–3.246) | p = 0.097 |
| Respiratory disease | 1.273 (0.558–2.905) | p = 0.567 | / | / |
| Malignancies | 1.141 (0.299–4.364) | p = 0.847 | / | / |
| DM | 1.984 (1.066–3.690) | p = 0.031 * | 1.638 (0.798–3.361) | p = 0.178 |
| Neurology disease | 1.059 (0.953–1.178) | p = 0.287 | / | / |
| Kidney disease | 0.599 (0.245–1.462) | p = 0.260 | / | / |
| Leukopenia | 2.279 (1.116–4.653) | p = 0.024 * | 2.659 (1.222–5.787) | p = 0.014 * |
| Lymphocytes | 1.805 (0.797–1.478) | p = 0.604 | / | / |
| Platelets | 0.999 (0.997–1.002) | p = 0.625 | / | / |
| Hemoglobin | 1.000 (0.991–1.010) | p = 0.934 | / | / |
| Ferritin | 0.539 (0.312–0.929) | p = 0.026 * | 0.686 (0.377–1.249) | p = 0.211 |
* Statistically significant.